Human breast cancer cells harboring a gatekeeper T798M mutation in HER2 overexpress EGFR ligands and are sensitive to dual inhibition of EGFR and HER2

Brent N. Rexer, Ritwik Ghosh, Archana Narasanna, Monica Valeria Estrada, Anindita Chakrabarty, Youngchul Song, Jeffrey A. Engelman, Carlos L. Arteaga

Research output: Contribution to journalArticle

44 Scopus citations

Fingerprint Dive into the research topics of 'Human breast cancer cells harboring a gatekeeper T798M mutation in HER2 overexpress EGFR ligands and are sensitive to dual inhibition of EGFR and HER2'. Together they form a unique fingerprint.

Medicine & Life Sciences